Live Breaking News & Updates on Ancer of the thyroid

Stay informed with the latest breaking news from Ancer of the thyroid on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ancer of the thyroid and stay connected to the pulse of your community

GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk

A cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.

Denmark , Sweden , Stockholm , Norway , Karolinska-institutet , Thyroid-cancer , Hyroid-carcinoma , Ancer-of-the-thyroid , Thyroid-disorder , Hyroid-disease , Hyroid-dysfunction

Study Suggests Inappropriate Use of Thyroid Ultrasounds

Of all new, dedicated thyroid ultrasounds performed at a single tertiary care center, only a quarter identified biopsy-recommended nodules, whereas nearly 40% did not find any nodules.

United-states , American , Trevore-angell , Davido-francis , Los-angeles , Elena-kennedy , Public-health , American-thyroid-association , University-of-wisconsin-school-medicine , University-of-wisconsin , Indiana-university-of-indianapolis , American-college-of-radiology

GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin

Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.

Lebanon , South-korea , New-york , United-states , Rachel-pessah , Dulaglutide-trulicity , Epic-research , University-of-north-carolina-at-chapel-hill , Novo-nordisk , While-the-epic-research , North-carolina , Chapel-hill

Nonsurgical Option for More Large Thyroid Nodule Patients?

When considering all large thyroid nodules > 4 cm, false negative rates declined compared with considering only large nodules in patients that had undergone surgery, in a new analysis.

United-states , Greece , American , Melbin-thomas , Rodisd-paparodis , Tracy-tylee , American-thyroid-association , University-of-washington , Medscape-medical , Annual-meeting , About-nodules , Having-high-false-negative-rates

Thyroid Cancer Increase Observed in Transgender Female Veterans

Thyroid cancer rates among transgender female veterans appear similar to those in cisgender women. Experts urge a cautious interpretation of the recent study results.

Washington , United-states , Sacramento , California , American , Maurice-garcia , John-christensen , Los-angeles , Sinai-medical-center , Health-program-at-cedars , Uc-davis-health , Division-of-endocrinology

Hold Blood Thinners During Thyroid Nodule Biopsy?

No significant differences in nondiagnostic results or hematomas seen when the blood thinners are continued, while discontinuing the medications may have risks.

Texas , United-states , Ohio , Cleveland , Houston , American , Pratibha-roa , Anastasios-maniakas , Michelle-lundholm , Society-of-interventional-radiology , International-society-on-thrombosis , Division-of-surgery

Triple Therapy Boosts Anaplastic Thyroid Cancer Survival

With the neoadjuvant regimen of pembrolizumab added to dabrafenib and trametinib, survival in BRAF-mutated forms of the highly aggressive cancer can go from months to more than 5 years.

United-states , Tampa , Florida , Texas , Washington , Houston , American , Sarah-hamidi , Mariae-cabanillas , Sarimar-agosto-salgado , H-lee-moffitt-cancer-center , Department-of-head